Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
20.3%
% of XBI's 119 holdings also in CNCR
33.3%
% of CNCR's 72 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
BLUEPRINT MEDICINES CORP. | 2.0% | 2.1% | 2.0% |
|
EXELIXIS INC | 1.9% | 2.7% | 1.9% |
|
REVOLUTION MEDICINES, INC. | 1.4% | 1.7% | 1.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | 1.2% | 2.7% | 1.2% |
|
REGENERON PHARMACEUTICALS | 2.3% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to CNCR
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
|
INSMED INC | 2.6% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.5% |
|
NATERA INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
BIOGEN IDEC INC | 2.5% |
|
AMGEN INC | 2.4% |
|
GILEAD SCIENCES INC | 2.4% |
|
ABBVIE INC | 2.4% |
XBI Underweight Relative to CNCR
|
INTREXON CORP | -3.2% |
|
RECURSION PHARMACEUTICALS, INC CLASS | -2.8% |
|
GENELUX CORP. | -2.5% |
|
BRISTOL-MYERS SQUIBB CO | -2.4% |
|
COMPASS THERAPEUTICS, INC. | -2.4% |
|
2SEVENTY BIO, INC. | -2.1% |
|
SCHRODINGER, INC. | -2.0% |
|
ZYMEWORKS INC. | -2.0% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.0% |
|
ENLIVEN THERAPEUTICS, INC. | -1.9% |